Mirderikvand, N., Mohammadzadeh Asl, B., Naserzadeh, P., Shaki, F., Shokrzadeh, M., Pourahmad, J. (2014). Embryo Toxic Effects of Depleted Uranium on the Morphology of the Mouse Fetus. Iranian Journal of Pharmaceutical Research, 13(1), 199-206.
Nina Mirderikvand; Baharak Mohammadzadeh Asl; Parvaneh Naserzadeh; Fatemeh Shaki; Mohammad Shokrzadeh; Jalal Pourahmad. "Embryo Toxic Effects of Depleted Uranium on the Morphology of the Mouse Fetus". Iranian Journal of Pharmaceutical Research, 13, 1, 2014, 199-206.
Mirderikvand, N., Mohammadzadeh Asl, B., Naserzadeh, P., Shaki, F., Shokrzadeh, M., Pourahmad, J. (2014). 'Embryo Toxic Effects of Depleted Uranium on the Morphology of the Mouse Fetus', Iranian Journal of Pharmaceutical Research, 13(1), pp. 199-206.
Mirderikvand, N., Mohammadzadeh Asl, B., Naserzadeh, P., Shaki, F., Shokrzadeh, M., Pourahmad, J. Embryo Toxic Effects of Depleted Uranium on the Morphology of the Mouse Fetus. Iranian Journal of Pharmaceutical Research, 2014; 13(1): 199-206.
Embryo Toxic Effects of Depleted Uranium on the Morphology of the Mouse Fetus
1Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2Department of Pharmacology and Toxicology, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3School of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
4-
Abstract
Abstract
Although the biokinetics, metabolism, and chemical toxicity of uranium are well known, until recently little attention was paid to the potential toxic effects of uranium on reproduction and development in mammals. In recent years, it has been shown that uranium is a developmental toxicant when given orally or subcutaneously (SC) to mice. Decreased fertility, embryo/fetal toxicity including teratogenicity, and reduced growth of the offspring have been observed following uranium exposure at different gestation periods. For investigating the effects of DU on pregnant animals, three groups (control, sham and test) of NMRI mice were chosen. In test group 4mg/kg of DU were administered intraperitonealy at 11 day of gestation, in sham group only normal saline injected to interior peritoneum as indicated in the test group and in Control group which was considered as the comparison base line of our research, no injection was made. Caesarean sections were performed at 15 day of the gestation; and their placentas were examined externally. Base on our results DU caused significant external anomalies, and caused a significant decrease (p<0.05) in the weight and diameter of placentas, the number of the embryos, their body weight and crown-rump length of fetuses.
Top